Viral Vector and Vaccine Market was valued at USD 8.5 Billion in 2022 and is projected to reach USD 24.3 Billion by 2030, growing at a CAGR of 14.2% from 2024 to 2030.
The global viral vector and vaccine market was valued at approximately USD 8.5 billion in 2022, with a compound annual growth rate (CAGR) of 7.2% projected from 2023 to 2028. The market's expansion is driven by the increasing prevalence of infectious diseases, advancements in gene therapy, and a rising focus on personalized medicine. Notably, the growing adoption of viral vector-based vaccines for new and emerging diseases is propelling the demand in the market. In addition, significant investments in research and development, coupled with supportive government initiatives, are expected to bolster market growth further.
Emerging markets present substantial opportunities, with the Asia-Pacific region showing the highest growth potential due to its large population base and improving healthcare infrastructure. Additionally, the expansion of healthcare access and rising awareness about advanced therapeutic options in these regions are anticipated to drive market growth. The accelerating trend towards the development of innovative vaccines and gene therapies is expected to offer lucrative opportunities for market players, particularly in regions with increasing biopharmaceutical research activities and investment in healthcare innovation.
Get an In-Depth Research Analysis of the Global Viral Vector and Vaccine Market Size And Forecast [2025-2032]
ABL
Addgene
Aldevron
Boehringer Ingelheim International GmbH
Brammer Bio
Charles River Laboratories
Creative-Biogene
Fujifilm Corporation
General Electric
MerckKGaA
Novasep
Pfizer
Spark Therapeutics
Thermo Fisher Scientific
Waisman Biomanufacturing
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Viral Vector and Vaccine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Viral Vector and Vaccine Market
Research Institutes
Biopharmaceutical Companies
Others
Based on Types the Market is categorized into Below types that held the largest Viral Vector and Vaccine market share In 2023.
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Viral Vector and Vaccine Market Research Analysis
1. Introduction of the Global Viral Vector and Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Viral Vector and Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Viral Vector and Vaccine Market, By Type
6. Global Viral Vector and Vaccine Market, By Application
7. Global Viral Vector and Vaccine Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Viral Vector and Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/